| Ytd | 35.21% | |
| 1y | -28.43% |
| Open | 7.19 | Prev Close | 7.54 | Low | 6.01 | High | 7.91 | Mkt Cap | 739.23M |
| Vol | 380.40K | Avg Vol | 278.19K | EPS | -0.04 | P/E | N/A | Forward P/E | 3.16 |
| Beta | 8.17 | Short Ratio | 18.64 | Inst. Own | 20.38% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 5.61 | 200-d Avg | 5.17 | 1yr Est | 0.00 |
CD&R pursues buyout of $40 billion payments processor Global Payments, FT reports
New York, NY, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Chaince Securities, LLC (“Chaince”), a FINRA-registe
U.S. FDA Approves Subcutaneous Induction Regimen for AbbVie's SKYRIZIÂ (risankizumab-rzaa) for Adult
Gainers Netcapital (NASDAQ:NCPL) shares increased by 29.9% to $2.12 during Tuesday's regular se
Gainers Atlantic American (NASDAQ:AAME) stock increased by 44.6% to $1.52 during Monday's pre-m
XP (NASDAQ: XP - Get Free Report) and Chindata Group (NASDAQ: CD - Get Free Report) are both finance
SKYRIZIÂ (risankizumab) and RINVOQÂ (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic
New York, NY, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Chaince Securities, LLC (“Chaince”), a FINRA-registe
U.S. futures mixed; Syndax plunged 17% after its lung fibrosis trial missed its endpoint. Zhibao, Ch
UnitedHealth rose after Q3 earnings and sales beat estimates; BIO-Key led gainers, while HUB Cyber S
Chindata Group (NASDAQ: CD - Get Free Report) and B. Riley Financial (NASDAQ: RILY - Get Free Report
New SKYRIZIÂ (risankizumab-rzaa) and RINVOQÂ (upadacitinib) Data Demonstrate Disease Control for Pat
Chindata Group Holdings Limited (NASDAQ: CD - Get Free Report)'s share price gapped down prior to tr
New York, NY, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Chaince Securities, LLC (“Chaince”), a FINRA-registe
U.S. stocks fell Monday, while Kodiak Sciences surged 174% after positive Phase 3 eye disease trial
Nasdaq fell 150+ points, while Everpure jumped 14% after unveiling growth plans and a FY2028 outlook
No Shares Issued; Company Has No Warrants Outstanding Following Cancellation No Shares Issued; Compa
New York, NY, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Chaince Securities, LLC (“Chaince”), a FINRA-regist
U.S. futures mixed; Oxford Industries fell 12.6% after mixed results. Lululemon, Guidewire, Asana an
Certain stocks are such poor bets that they are likely to lose ground even in bull markets.
Chaince Digital Holdings Inc. (CD) Shareholder/Analyst Call Transcript
Chaince Digital Holdings Inc. Up to $300,000,000Ordinary Shares This prospectus supplement relates t
Strong growth from Vyepti and focused commercial execution drive total revenue growth of +16% CER (
Chaince Digital Holdings Inc. (NASDAQ:CD) ("Chaince Digital" or the "Company") (form
NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Chaince Digital Holdings Inc. (Nasdaq: CD) (“Chaince Di
New York, NY, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Chaince Securities, LLC (“Chaince”), a FINRA-registe
New York, NY, July 14, 2026 (GLOBE NEWSWIRE) -- Chaince Securities, LLC (“Chaince”), a FINRA-registe
Chaince Digital Holdings Inc. ("Chaince Digital" or the "Company") (NASDAQ:CD) (form
NEW YORK, NY, July 07, 2026 (GLOBE NEWSWIRE) -- Chaince Digital Holdings Inc. (“Chaince Digital” or
NEW YORK, NY, June 15, 2026 (GLOBE NEWSWIRE) -- Chaince Digital Holdings Inc. (“Chaince Digital” or
NEW YORK, NY, June 11, 2026 (GLOBE NEWSWIRE) -- Chaince Digital Holdings Inc. (Nasdaq: CD) (“Chaince
U.S. stocks higher, Dow Jones up 150 points. Soleno Therapeutics jumps 32%, Playtika Holding launche
Chaince Digital Holdings Inc. ("Chaince Digital" or the "Company") (NASDAQ:CD) (form
The Company also announced today that it has requested that trading of its ADSs on the Nasdaq Global
Chindata Group Holdings (NASDAQ:CD) reported quarterly EPADS of $0.08 per share. This is a 20 percen
Keybanc lowered the price target for Bumble Inc. (NASDAQ: BMBL) from $25 to $24. Keybanc analyst
Jefferies analyst Edison Lee downgrades Chindata Group Holdings (NASDAQ:CD) from Buy to Hold and
The most overbought stocks in the information technology sector presents an opportunity to go short
Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Tech